Q-Line BiotechNSE:QLINE -5.15%12 Quick Ratio is 0.97 as of Mar. 2025, which is at its 10-year median of 0.97. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Q-Line Biotech ranks worse than 78.57% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Q-Line Biotech's quick ratio for the quarter that ended in Mar. 2025 was 0.97.
Q-Line Biotech has a quick ratio of 0.97. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Q-Line Biotech's Quick Ratio or its related term are showing as below:
NSE:QLINE'
s Quick Ratio Range Over the Past 10 Years
Min: 0.67 Med: 0.97 Max: 1.23
Current: 0.97
During the past 3 years, Q-Line Biotech's highest Quick Ratio was 1.23. The lowest was 0.67. And the median was 0.97.
NSE:QLINE's Quick Ratio is ranked worse than 78.57% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs NSE:QLINE: 0.97
Q-Line Biotech (NSE:QLINE) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Q-Line Biotech Quick Ratio Related Terms
Q-Line Biotech Quick Ratio Historical Data
* Premium members only.
The historical data trend for Q-Line Biotech's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-Line Biotech Quick Ratio Chart
Q-Line Biotech Annual Data
Trend
Mar23
Mar24
Mar25
Quick Ratio
1.23
0.67
0.97
Q-Line Biotech Semi-Annual Data
Mar23
Mar24
Mar25
Quick Ratio
1.23
0.67
0.97
NSE:QLINE vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Q-Line Biotech's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-Line Biotech Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-Line Biotech's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Q-Line Biotech's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Q-Line Biotech's Quick Ratio for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-Line Biotech (NSE:QLINE) has a Quick Ratio of 0.97 as of Mar. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Q-Line Biotech and its competitors. This is near median its historical median of 0.97. Over the past decade, Q-Line Biotech's Quick Ratio has ranged from 0.67 to 1.23. According to the industry distribution chart, Q-Line Biotech ranks #671 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 78.6%.
Is Q-Line Biotech's Quick Ratio too high?
Q-Line Biotech's current Quick Ratio of 0.97 is near median its 10-year median of 0.97. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 1.23. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Q-Line Biotech's value of 0.97 is 48% below this industry median. Based on the distribution chart, Q-Line Biotech ranks #671 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Q-Line Biotech ranks #671 out of 854 companies for Quick Ratio. This places Q-Line Biotech in the lower half of its industry. The industry median Quick Ratio is 1.87. Q-Line Biotech's value of 0.97 is 48% below this benchmark. Historically, Q-Line Biotech's own Quick Ratio has ranged from 0.67 to 1.23 over the past decade. While the company's 10-year median is 0.97 vs. the industry median of 1.87, Q-Line Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Q-Line Biotech's current Quick Ratio of 0.97 is 48% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Q-Line Biotech and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q-Line Biotech's current Quick Ratio is 0.97, which is near median its own 10-year median of 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Quick Ratio of 0.97. The current Quick Ratio is 0.97, which is near median its 10-year median of 0.97 and 48% below the Medical Devices & Instruments industry median of 1.87. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Quick Ratio is 0.97 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score
Get the complete analysis for NSE:QLINE
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QLINE has been successfully added to your 